<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31958204</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1601-0825</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>May</Month></PubDate></JournalIssue><Title>Oral diseases</Title><ISOAbbreviation>Oral Dis</ISOAbbreviation></Journal><ArticleTitle>Exosomes from EV71-infected oral epithelial cells can transfer miR-30a to promote EV71 infection.</ArticleTitle><Pagination><StartPage>778</StartPage><EndPage>788</EndPage><MedlinePgn>778-788</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/odi.13283</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">As an extracellular vesicle, exosomes can release from virus-infected cells containing various viral or host cellular elements and could stimulate recipient's cellular response. Enterovirus 71 (EV71), a single-strand positive-sense RNA virus, is known to cause hand, foot, and mouth disease (HFMD) in children and bring about severe clinical diseases.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Separated the human oral epithelial cells (OE cells) from normal buccal mucosa through enzyme digestion. Performed a comprehensive miRNA profiling in exosomes from EV71-infected OE cells through deep small RNA-seq. Using the Human Antiviral Response RT Profiler PCR Array profiles to explore the interactions of innate immune signaling networks with exosomal miR-30a. Knocked out the MyD88 gene in macrophages using CRISPR/Cas9-mediated genome editing method.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our study demonstrated that the miR-30a was preferentially enriched in exosomes that released from EV71-infected human oral epithelial cells through small RNA-seq. We found that the transfer of exosomal miR-30a to macrophages could suppress type &#x2160; interferon response through targeting myeloid differentiation factor 88 (MyD88) and subsequently facilitate the viral replication.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Exosomes released from EV71-infected OE cells selectively packaged high level of miR-30a that can be functionally transferred to the recipient macrophages resulted in targeting MyD88 and subsequently inhibited type I interferon production in receipt cells, thus promoting the EV71 replication.</AbstractText><CopyrightInformation>&#xa9; 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9320-8438</Identifier><AffiliationInfo><Affiliation>The Affiliated Suzhou Science &amp; Technology Town Hospital of Nanjing Medical University, Suzhou Science &amp; Technology Town Hospital, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shuting</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthodontics, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Weijian</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The Affiliated Suzhou Science &amp; Technology Town Hospital of Nanjing Medical University, Suzhou Science &amp; Technology Town Hospital, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Weixin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>The Affiliated Suzhou Science &amp; Technology Town Hospital of Nanjing Medical University, Suzhou Science &amp; Technology Town Hospital, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jiasu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The Affiliated Suzhou Science &amp; Technology Town Hospital of Nanjing Medical University, Suzhou Science &amp; Technology Town Hospital, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chengxi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Affiliated Suzhou Science &amp; Technology Town Hospital of Nanjing Medical University, Suzhou Science &amp; Technology Town Hospital, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yingying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Affiliated Suzhou Science &amp; Technology Town Hospital of Nanjing Medical University, Suzhou Science &amp; Technology Town Hospital, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Yuanchun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Affiliated Suzhou Science &amp; Technology Town Hospital of Nanjing Medical University, Suzhou Science &amp; Technology Town Hospital, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>The Affiliated Suzhou Science &amp; Technology Town Hospital of Nanjing Medical University, Suzhou Science &amp; Technology Town Hospital, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Affiliated Suzhou Science &amp; Technology Town Hospital of Nanjing Medical University, Suzhou Science &amp; Technology Town Hospital, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Bin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthodontics, Affiliated Hospital of Stomatology, Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Oral Dis</MedlineTA><NlmUniqueID>9508565</NlmUniqueID><ISSNLinking>1354-523X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007370">Interferon Type I</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C546086">MIRN30b microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507779">MYD88 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053594">Myeloid Differentiation Factor 88</NameOfSubstance></Chemical></ChemicalList><MeshHeadingList><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055354" MajorTopicYN="N">Exosomes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055786" MajorTopicYN="N">Gene Knockout Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007370" MajorTopicYN="N">Interferon Type I</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053594" MajorTopicYN="N">Myeloid Differentiation Factor 88</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000081246" MajorTopicYN="N">RNA-Seq</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">MyD88</Keyword><Keyword MajorTopicYN="N">exosomes</Keyword><Keyword MajorTopicYN="N">has-miR-30a</Keyword><Keyword MajorTopicYN="N">type I interferon</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31958204</ArticleId><ArticleId IdType="doi">10.1111/odi.13283</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Alenquer, M., &amp; Amorim, M. J. (2015). Exosome biogenesis, regulation, and function in viral infection. Viruses, 7, 5066-5083.</Citation></Reference><Reference><Citation>Bukong, T. N., Momen-Heravi, F., Kodys, K., Bala, S., &amp; Szabo, G. (2014). Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Path, 10, e1004424.</Citation></Reference><Reference><Citation>Chahar, H. S., Bao, X., &amp; Casola, A. (2015). Exosomes and their role in the life cycle and pathogenesis of RNA viruses. Viruses, 7, 3204-3225.</Citation></Reference><Reference><Citation>Colao, I. L., Corteling, R., Bracewell, D., &amp; Wall, I. (2018). Manufacturing exosomes: A promising therapeutic platform. Trends in Molecular Medicine, 24, 242-256.</Citation></Reference><Reference><Citation>Crenshaw, B. J., Gu, L., Sims, B., &amp; Matthews, Q. L. (2018). Exosome biogenesis and biological function in response to viral infections. The Open Virology Journal, 12, 134-148.</Citation></Reference><Reference><Citation>Deguine, J., &amp; Barton, G. M. (2014). MyD88: A central player in innate immune signaling .F1000prime Reports, 6, 97.</Citation></Reference><Reference><Citation>Dreux, M., Garaigorta, U., Boyd, B., Decembre, E., Chung, J., Whitten-Bauer, C., &#x2026; Chisari, F. V. (2012). Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host &amp; Microbe, 12, 558-570.</Citation></Reference><Reference><Citation>Feller, L., Altini, M., Khammissa, R. A., Chandran, R., Bouckaert, M., &amp; Lemmer, J. (2013). Oral mucosal immunity. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 116, 576-583.</Citation></Reference><Reference><Citation>Forster, S. C., Tate, M. D., &amp; Hertzog, P. J. (2015). MicroRNA as type I interferon-regulated transcripts and modulators of the innate immune response. Frontiers in Immunology, 6, 334.</Citation></Reference><Reference><Citation>Fu, Y., Xu, W., Chen, D., Feng, C., Zhang, L., Wang, X., &#x2026; Wu, Z. (2015). Enterovirus 71 induces autophagy by regulating has-miR-30a expression to promote viral replication. Antiviral Research, 124, 43-53.</Citation></Reference><Reference><Citation>Fu, Y., Zhang, L., Zhang, F., Tang, T., Zhou, Q., Feng, C., &#x2026; Wu, Z. (2017). Exosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection. PLoS Path, 13, e1006611.</Citation></Reference><Reference><Citation>Gurwitz, D. (2015). Exosomal MicroRNAs in tissue crosstalk. Drug Development Research, 76, 259-262.</Citation></Reference><Reference><Citation>Hassona, Y., &amp; Scully, C. (2016). Salivary changes in oral mucosal diseases. Periodontology, 2000(70), 111-127.</Citation></Reference><Reference><Citation>Hu, G., Yao, H., Chaudhuri, A. D., Duan, M., Yelamanchili, S. V., Wen, H., &#x2026; Buch, S. (2012). Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction. Cell Death &amp; Disease, 3, e381.</Citation></Reference><Reference><Citation>Huang, C. B., Alimova, Y., &amp; Ebersole, J. L. (2016). Macrophage polarization in response to oral commensals and pathogens. Pathogens and Disease 74, ftw011.</Citation></Reference><Reference><Citation>Huang, X., Yuan, T., Tschannen, M., Sun, Z., Jacob, H., Du, M., &#x2026; Wang, L. (2013). Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics, 14, 319.</Citation></Reference><Reference><Citation>Jiang, L. H., Zhang, H. D., &amp; Tang, J. H. (2018). MiR-30a: A novel biomarker and potential therapeutic target for cancer. Journal of Oncology, 2018, 5167829.</Citation></Reference><Reference><Citation>Jin, Y., Zhang, R., Wu, W., &amp; Duan, G. (2018). Antiviral and inflammatory cellular signaling associated with enterovirus 71 infection. Viruses, 10(4), pii: E155. https://doi.org/10.3390/v10040155</Citation></Reference><Reference><Citation>Kouwaki, T., Okamoto, M., Tsukamoto, H., Fukushima, Y., &amp; Oshiumi, H. (2017). Extracellular vesicles deliver host and virus RNA and regulate innate immune response. International Journal of Molecular Sciences, 18(3), pii: E666. https://doi.org/10.3390/ijms18030666</Citation></Reference><Reference><Citation>Lagos, D., Pollara, G., Henderson, S., Gratrix, F., Fabani, M., Milne, R. S., &#x2026; Boshoff, C. (2010). miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nature Cell Biology, 12, 513-519.</Citation></Reference><Reference><Citation>Machida, T., Tomofuji, T., Ekuni, D., Maruyama, T., Yoneda, T., Kawabata, Y., &#x2026; Morita, M. (2015). MicroRNAs in salivary exosome as potential biomarkers of aging. International Journal of Molecular Sciences, 16, 21294-21309.</Citation></Reference><Reference><Citation>Michalczyk, A., Varigos, G., Smith, L., &amp; Ackland, M. L. (2004). Fresh and cultured buccal cells as a source of mRNA and protein for molecular analysis. BioTechniques, 37(262-4), 266-269. https://doi.org/10.2144/04372RR03</Citation></Reference><Reference><Citation>Ng, Q., He, F., &amp; Kwang, J. (2015). Recent progress towards novel EV71 anti-therapeutics and vaccines. Viruses, 7, 6441-6457.</Citation></Reference><Reference><Citation>Nolte-'t Hoen, E., Cremer, T., Gallo, R. C., &amp; Margolis, L. B. (2016). Extracellular vesicles and viruses: Are they close relatives? Proceedings of the National Academy of Sciences, 113(33), 9155-9161.</Citation></Reference><Reference><Citation>Pathinayake, P. S., Hsu, A. C., &amp; Wark, P. A. (2015). Innate immunity and immune evasion by enterovirus 71. Viruses, 7, 6613-6630.</Citation></Reference><Reference><Citation>Pegtel, D. M., &amp; Gould, S. J. (2019). Exosomes. Annual Review of Biochemistry, 88, 487-514.</Citation></Reference><Reference><Citation>Pegtel, D. M., Peferoen, L., &amp; Amor, S. (2014). Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 369, pii: 20130516.</Citation></Reference><Reference><Citation>Pourianfar, H. R., &amp; Grollo, L. (2015). Development of antiviral agents toward enterovirus 71 infection.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi, 48, 1-8.</Citation></Reference><Reference><Citation>Rastogi, M., &amp; Singh, S. K. (2019). Modulation of type-I interferon response by hsa-miR-374b-5p during Japanese encephalitis virus infection in human microglial cells. Frontiers in Cellular and Infection Microbiology, 9, 291.</Citation></Reference><Reference><Citation>Rekker, K., Saare, M., Roost, A. M., Kubo, A. L., Zarovni, N., Chiesi, A., &#x2026; Peters, M. (2014). Comparison of serum exosome isolation methods for microRNA profiling. Clinical Biochemistry, 47, 135-138.</Citation></Reference><Reference><Citation>Saeed, M. I., Omar, A. R., Hussein, M. Z., Elkhidir, I. M., &amp; Sekawi, Z. (2015). Development of enhanced antibody response toward dual delivery of nano-adjuvant adsorbed human Enterovirus-71 vaccine encapsulated carrier. Human Vaccines &amp; Immunotherapeutics, 11, 2414-2424.</Citation></Reference><Reference><Citation>Schwab, A., Meyering, S. S., Lepene, B., Iordanskiy, S., van Hoek, M. L., Hakami, R. M., &amp; Kashanchi, F. (2015). Extracellular vesicles from infected cells: Potential for direct pathogenesis. Frontiers in Microbiology, 6, 1132.</Citation></Reference><Reference><Citation>Shah, R., Patel, T., &amp; Freedman, J. E. (2018). Circulating extracellular vesicles in human disease. The New England Journal of Medicine, 379, 958-966.</Citation></Reference><Reference><Citation>Shrivastava, S., Devhare, P., Sujijantarat, N., Steele, R., Kwon, Y. C., Ray, R., &amp; Ray, R. B. (2016). Knockdown of autophagy inhibits infectious hepatitis C virus release by the exosomal pathway. Journal of Virology, 90, 1387-1396.</Citation></Reference><Reference><Citation>Squadrito, M. L., Baer, C., Burdet, F., Maderna, C., Gilfillan, G. D., Lyle, R., &#x2026; De Palma, M. (2014). Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Reports, 8, 1432-1446.</Citation></Reference><Reference><Citation>Turchinovich, A., Weiz, L., Langheinz, A., &amp; Burwinkel, B. (2011). Characterization of extracellular circulating microRNA. Nucleic Acids Research, 39, 7223-7233.</Citation></Reference><Reference><Citation>van Niel, G., D'Angelo, G., &amp; Raposo, G. (2018). Shedding light on the cell biology of extracellular vesicles. Nature Reviews Molecular Cell Biology, 19(4), 213-228. https://doi.org/10.1038/nrm.2017.125</Citation></Reference><Reference><Citation>Villarroya-Beltri, C., Gutierrez-Vazquez, C., Sanchez-Cabo, F., Perez-Hernandez, D., Vazquez, J., Martin-Cofreces, N., &#x2026; Sanchez-Madrid, F. (2013). Sumoylated hnRNPA2B1 Controls the sorting of miRNAs into exosomes through binding to specific motifs. Nature Communications, 4, 2980.</Citation></Reference><Reference><Citation>Vlassov, A. V., Magdaleno, S., Setterquist, R., &amp; Conrad, R. (2012). Exosomes: Current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochimica et Biophysica Acta, 1820, 940-948.</Citation></Reference><Reference><Citation>Wang, S. M., Lei, H. Y., &amp; Liu, C. C. (2012). Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clinical &amp; Developmental Immunology, 2012, 876241.</Citation></Reference><Reference><Citation>Wu, Y., Sun, Q., &amp; Dai, L. (2017). Immune regulation of miR-30 on the Mycobacterium tuberculosis-induced TLR/MyD88 signaling pathway in THP-1 cells. Experimental and Therapeutic Medicine, 14, 3299-3303.</Citation></Reference><Reference><Citation>Xiao, X., Qi, J., Lei, X., &amp; Wang, J. (2019). Interactions between enteroviruses and the inflammasome: New insights into viral pathogenesis. Frontiers in Microbiology, 10, 321.</Citation></Reference><Reference><Citation>Yi, E. J., Shin, Y. J., Kim, J. H., Kim, T. G., &amp; Chang, S. Y. (2017). Enterovirus 71 infection and vaccines. Clinical and Experimental Vaccine Research, 6, 4-14.</Citation></Reference><Reference><Citation>Yip, C. C., Lau, S. K., Woo, P. C., &amp; Yuen, K. Y. (2013). Human enterovirus 71 epidemics: What's next? Emerging Health Threats Journal, 6, 19780. https://doi.org/10.3402/ehtj.v6i0.19780</Citation></Reference><Reference><Citation>Yoshizawa, J. M., &amp; Wong, D. T. (2013). Salivary microRNAs and oral cancer detection. Methods in Molecular Biology, 936, 313-324.</Citation></Reference><Reference><Citation>Zhang, J., Li, S., Li, L., Li, M., Guo, C., Yao, J., &amp; Mi, S. (2015). Exosome and exosomal microRNA: Trafficking, sorting, and function. Genomics, Proteomics &amp; Bioinformatics, 13, 17-24.</Citation></Reference><Reference><Citation>Zhou, C., Tan, L., Sun, Y., Qiu, X., Meng, C., Liao, Y., &#x2026; Ding, C. (2019). Exosomes carry microRNAs into neighboring cells to promote diffusive infection of Newcastle disease virus. Viruses, 11(6), pii: E527.</Citation></Reference><Reference><Citation>Zhou, Y., Li, J. X., Jin, P. F., Wang, Y. X., &amp; Zhu, F. C. (2016). Enterovirus 71: A whole virion inactivated enterovirus 71 vaccine. Expert Review of Vaccines, 15, 803-813.</Citation></Reference><Reference><Citation>Zhu, F., Xu, W., Xia, J., Liang, Z., Liu, Y., Zhang, X., &#x2026; Wang, N. (2014). Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. The New England Journal of Medicine, 370, 818-828.</Citation></Reference><Reference><Citation>Zhu, X., He, Z., Yuan, J., Wen, W., Huang, X., Hu, Y., &#x2026; Li, M. (2015). IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection. Cellular Microbiology, 17, 105-118.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>